Top

Published in:

Open Access 01-12-2014 | Letter to the Editor

Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates

Authors: Achim Thomzig, Katja Wagenführ, Martin L Daus, Marion Joncic, Walter J Schulz-Schaeffer, Marc Thanheiser, Martin Mielke, Michael Beekes

Published in: Acta Neuropathologica Communications | Issue 1/2014

Abstract

No abstract

Available only for authorised users

Come JH, Fraser PE, Lansbury PT: A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci U S A 1993, 90: 5959–5963. 10.1073/pnas.90.13.5959CrossRefPubMedPubMedCentral

Harper JD, Lansbury PT Jr: Models of amyloid seeding in Alzheimer’s disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 1997, 66: 385–407. 10.1146/annurev.biochem.66.1.385CrossRefPubMed

Chiti F, Dobson CM: Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006, 75: 333–366. 10.1146/annurev.biochem.75.101304.123901CrossRefPubMed

Beekes M, Thomzig A, Schulz-Schaeffer WJ, Burger R: Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles? Acta Neuropathol 2014, 128: 463–476. 10.1007/s00401-014-1324-9CrossRefPubMedPubMedCentral

Eisele YS, Bolmont T, Heikenwalder M, Langer F, Jacobson LH, Yan ZX, Roth K, Aguzzi A, Staufenbiel M, Walker LC, Jucker M: Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci U S A 2009, 106: 12926–12931. 10.1073/pnas.0903200106CrossRefPubMedPubMedCentral

Fritschi SK, Cintron A, Ye L, Mahler J, Bühler A, Baumann F, Neumann M, Nilsson KP, Hammarström P, Walker LC, Jucker M: Abeta seeds resist inactivation by formaldehyde. Acta Neuropathol 2014, 128: 477–484. 10.1007/s00401-014-1339-2CrossRefPubMedPubMedCentral

Luk KC, Kehm VM, Zhang B, O’Brien P, Trojanowski JQ, Lee VM: Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 2012, 209: 975–986. 10.1084/jem.20112457CrossRefPubMedPubMedCentral

Watts JC, Giles K, Oehler A, Middleton L, Dexter DT, Gentleman SM, DeArmond SJ, Prusiner SB: Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci U S A 2013, 110: 19555–19560. 10.1073/pnas.1318268110CrossRefPubMedPubMedCentral

Sacino AN, Brooks M, Thomas MA, McKinney AB, Lee S, Regenhardt RW, McGarvey NH, Ayers JI, Notterpek L, Borchelt DR, Golde TE, Giasson BI: Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc Natl Acad Sci U S A 2014, 111: 10732–10737. 10.1073/pnas.1321785111CrossRefPubMedPubMedCentral

10.

Recasens A, Dehay B, Bove J, Carballo-Carbajal I, Dovero S, Pérez-Villalba A, Fernagut PO, Blesa J, Parent A, Perier C, Fariñas I, Obeso JA, Bezard E, Vila M: Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol 2014, 75: 351–362. 10.1002/ana.24066CrossRefPubMed

11.

Beekes M, Lemmer K, Thomzig A, Joncic M, Tintelnot K, Mielke M: Fast, broad-range disinfection of bacteria, fungi, viruses and prions. J Gen Virol 2010, 91: 580–589. 10.1099/vir.0.016337-0CrossRefPubMed

12.

Duran-Aniotz C, Morales R, Moreno-Gonzalez I, Hu PP, Fedynyshyn J, Soto C: Aggregate-depleted brain fails to induce Abeta deposition in a mouse model of Alzheimer’s disease. PLoS One 2014, 9: e89014. 10.1371/journal.pone.0089014CrossRefPubMedPubMedCentral

13.

Baier M, Schwarz A, Mielke M: Activity of an alkaline ‘cleaner' in the inactivation of the scrapie agent. J Hosp Infect 2004, 57: 80–84. 10.1016/j.jhin.2004.01.013CrossRefPubMed

14.

Lehmann S, Rauwel GPM, Rogez-Kreuz C, Richard M, Belondrade M, Rauwel G, Durand F, Yousfi R, Criquelion J, Clayette P, Perret-Liaudet A: New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive equipment. J Hosp Infect 2009, 72: 342–350. 10.1016/j.jhin.2009.03.024CrossRefPubMed

Title: Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates
Authors: Achim Thomzig
Katja Wagenführ
Martin L Daus
Marion Joncic
Walter J Schulz-Schaeffer
Marc Thanheiser
Martin Mielke
Michael Beekes
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: Acta Neuropathologica Communications / Issue 1/2014
Electronic ISSN: 2051-5960
DOI: https://doi.org/10.1186/s40478-014-0151-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial

β-amyloid induces a dying-back process and remote trans-synaptic alterations in a microfluidic-based reconstructed neuronal network

Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice

Stereological study of the neuronal number and volume of 38 brain subdivisions of subjects diagnosed with autism reveals significant alterations restricted to the striatum, amygdala and cerebellum

Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis

MotorPlex provides accurate variant detection across large muscle genes both in single myopathic patients and in pools of DNA samples